Paris - Delayed Quote EUR
Transgene SA (TNG.PA)
0.5960
+0.0080
+(1.36%)
As of 11:00:19 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-23,548
-23,548
-34,671
-20,303
-25,909
Investing Cash Flow
-3,206
-3,206
34,572
20,272
-5,789
Financing Cash Flow
26,959
26,959
11,369
-1,477
32,320
End Cash Position
16,670
16,670
15,666
4,403
5,911
Capital Expenditure
-3,075
-3,075
-2,746
-1,535
-686
Issuance of Capital Stock
0
0
0
0
34,129
Issuance of Debt
36,150
36,150
12,859
0
--
Repayment of Debt
-7,500
-7,500
0
0
-197
Free Cash Flow
-26,623
-26,623
-37,417
-21,838
-26,595
12/31/2021 - 4/12/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALVIO.PA Valerio Therapeutics Société anonyme
0.0626
-0.60%
IPH.PA Innate Pharma S.A.
1.9500
-0.10%
ADOC.PA Adocia SA
4.9300
-6.00%
NANO.PA Nanobiotix S.A.
3.3300
-4.03%
GNFT.PA Genfit S.A.
3.6220
-4.23%
DBV.PA DBV Technologies S.A.
1.9980
-11.97%
RNXT RenovoRx, Inc.
1.0500
+1.94%
BCYC Bicycle Therapeutics plc
8.01
-1.23%
KURA Kura Oncology, Inc.
5.73
-1.21%
RLAY Relay Therapeutics, Inc.
2.7700
-2.12%